Research backs this up: Young men who consumed more protein while losing weight and on an intense exercise regiment gained ...
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.
How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together ...
As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...
When you weigh nearly 20 stone, small everyday things are fraught with anxiety. There are so many worries regular-sized ...
More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...
Food manufacturers are trying to whip themselves up a forkful of the slimming trend — but nutrition experts aren’t giving them a good review.
Nina King says that Ozempic's rise could shift beauty standards away from thinness as it becomes more accessible.
Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...
The explosive rise of GLP-1 drugs like Ozempic has brought an accompanying challenge: logistics too knotty for a single ...